Wall Street has placed a big bet on GLP-1 drugs. When Walmart’s U.S. CEO, John Furner, told Bloomberg in October 2023 that ...
AstraZeneca is driven by a diversified portfolio, robust R&D, and strong FCF, despite a current valuation that is slightly ...
Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...
This factory lightweight made the Corvette look slow for 56 years and it didn't even have a big block. It was using a dated ...
Four California dynos tested the same Mustang Dark Horse and couldn't agree on what Ford's 500 hp claim means at the wheels ...
Our free daily newsletter sends the stories that really matter directly to you, every weekday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results